A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

NCT01860508 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: pemetrexed /carboplatin

Sponsor

Fudan University